Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 538

1.

Comparative analysis of genes regulated by PML/RAR alpha and PLZF/RAR alpha in response to retinoic acid using oligonucleotide arrays.

Park DJ, Vuong PT, de Vos S, Douer D, Koeffler HP.

Blood. 2003 Nov 15;102(10):3727-36. Epub 2003 Jul 31.

2.

Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase.

Benedetti L, Grignani F, Scicchitano BM, Jetten AM, Diverio D, Lo Coco F, Avvisati G, Gambacorti-Passerini C, Adamo S, Levin AA, Pelicci PG, Nervi C.

Blood. 1996 Mar 1;87(5):1939-50.

3.

A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation.

Shao W, Benedetti L, Lamph WW, Nervi C, Miller WH Jr.

Blood. 1997 Jun 15;89(12):4282-9.

4.
5.

AM580, a stable benzoic derivative of retinoic acid, has powerful and selective cyto-differentiating effects on acute promyelocytic leukemia cells.

Gianní M, Li Calzi M, Terao M, Guiso G, Caccia S, Barbui T, Rambaldi A, Garattini E.

Blood. 1996 Feb 15;87(4):1520-31.

6.

Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.

Rusiniak ME, Yu M, Ross DT, Tolhurst EC, Slack JL.

Cancer Res. 2000 Apr 1;60(7):1824-9.

7.

The PML/RAR alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells.

Raelson JV, Nervi C, Rosenauer A, Benedetti L, Monczak Y, Pearson M, Pelicci PG, Miller WH Jr.

Blood. 1996 Oct 15;88(8):2826-32.

8.

Formation of PML/RAR alpha high molecular weight nuclear complexes through the PML coiled-coil region is essential for the PML/RAR alpha-mediated retinoic acid response.

Grignani F, Gelmetti V, Fanelli M, Rogaia D, De Matteis S, Ferrara FF, Bonci D, Grignani F, Nervi C, Pelicci PG.

Oncogene. 1999 Nov 4;18(46):6313-21.

10.

PRAM-1 is a novel adaptor protein regulated by retinoic acid (RA) and promyelocytic leukemia (PML)-RA receptor alpha in acute promyelocytic leukemia cells.

Moog-Lutz C, Peterson EJ, Lutz PG, Eliason S, Cavé-Riant F, Singer A, Di Gioia Y, Dmowski S, Kamens J, Cayre YE, Koretzky G.

J Biol Chem. 2001 Jun 22;276(25):22375-81. Epub 2001 Apr 11.

11.

PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors.

Chen Z, Guidez F, Rousselot P, Agadir A, Chen SJ, Wang ZY, Degos L, Zelent A, Waxman S, Chomienne C.

Proc Natl Acad Sci U S A. 1994 Feb 1;91(3):1178-82.

12.

Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signalling.

Ruthardt M, Testa U, Nervi C, Ferrucci PF, Grignani F, Puccetti E, Grignani F, Peschle C, Pelicci PG.

Mol Cell Biol. 1997 Aug;17(8):4859-69.

14.

Retinoic acid receptors: involvement in acute promyelocytic leukemia.

Agadir A, Cornic M, Gourmel B, Lefebvre P, Degos L, Chomienne C.

Cell Mol Biol (Noisy-le-grand). 1994 May;40(3):263-74. Review.

PMID:
7920173
15.

Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)-associated acute promyelocytic leukemia.

Licht JD, Shaknovich R, English MA, Melnick A, Li JY, Reddy JC, Dong S, Chen SJ, Zelent A, Waxman S.

Oncogene. 1996 Jan 18;12(2):323-36.

PMID:
8570209
16.
18.

Targeting the PML/RAR alpha translocation product triggers apoptosis in promyelocytic leukemia cells.

Nason-Burchenal K, Takle G, Pace U, Flynn S, Allopenna J, Martin P, George ST, Goldberg AR, Dmitrovsky E.

Oncogene. 1998 Oct 8;17(14):1759-68.

19.

Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.

Ahn MJ, Nason-Burchenal K, Moasser MM, Dmitrovsky E.

Oncogene. 1995 Jun 15;10(12):2307-14.

PMID:
7784078
20.

Establishment and characterization of a novel acute promyelocytic leukemia cell line (UF-1) with retinoic acid-resistant features.

Kizaki M, Matsushita H, Takayama N, Muto A, Ueno H, Awaya N, Kawai Y, Asou H, Kamada N, Ikeda Y.

Blood. 1996 Sep 1;88(5):1824-33.

Supplemental Content

Support Center